Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 5,000 shares at $611.00 ($3.1M) on 2021-08-10, disclosed to the SEC on 2021-08-10.
Open-market sale of $3.1M REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $607.51 | 1,636 | $994K | 32.4% |
| 2 | $610.85 | 1 | $611 | 0.0% |
| 3 | $612.97 | 36 | $22K | 0.7% |
| 4 | $613.79 | 1 | $614 | 0.0% |
| 5 | $614.70 | 66 | $41K | 1.3% |
| 6 | $615.42 | 40 |
| $25K |
| 0.8% |
| 7 | $617.68 | 2,463 | $1.5M | 49.6% |
| 8 | $617.83 | 36 | $22K | 0.7% |
| 9 | $618.44 | 58 | $36K | 1.2% |
| 10 | $619.70 | 36 | $22K | 0.7% |
| 11 | $621.19 | 54 | $34K | 1.1% |
| 12 | $623.54 | 36 | $22K | 0.7% |
| 13 | $611.00 | 433 | $265K | 8.6% |
| 14 | $612.31 | 50 | $31K | 1.0% |
| 15 | $614.09 | 1 | $614 | 0.0% |
| 16 | $615.73 | 1 | $616 | 0.0% |
| 17 | $618.89 | 45 | $28K | 0.9% |
| 18 | $619.19 | 7 | $4K | 0.1% |
| Total | $613.74 avg | 5,000 | $3.1M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |